Radiation plus Temozolomide in Patients with Glioblastoma

Affiliations

¹ University of Colorado School of Medicine, Aurora, CO chad.rusthoven@ucdenver.edu
² University of Chicago Pritzker School of Medicine, Chicago, IL
³ University of Texas Southwestern Medical School, Dallas, TX

Comment

Chad G Rusthoven et al. N Engl J Med. 2017.

. 2017 Jun 1;376(22):2195-2197.

doi: 10.1056/NEJMc1704726.

¹ University of Colorado School of Medicine, Aurora, CO chad.rusthoven@ucdenver.edu
² University of Chicago Pritzker School of Medicine, Chicago, IL
³ University of Texas Southwestern Medical School, Dallas, TX

No abstract available

Comment in

Radiation plus Temozolomide in Patients with Glioblastoma.
Perry JR, Laperriere N, Mason WP. Perry JR, et al. N Engl J Med. 2017 Jun 1;376(22):2197. doi: 10.1056/NEJMc1704726. N Engl J Med. 2017. PMID: 28564572 No abstract available.

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
Perry JR, Laperriere N, O'Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Back M, Tills M, Winch C, Baumert BG, Wick W, Ding K, Mason WP; Trial Investigators. Perry JR, et al. N Engl J Med. 2017 Mar 16;376(11):1027-1037. doi: 10.1056/NEJMoa1611977. N Engl J Med. 2017. PMID: 28296618 Clinical Trial.